Michael A. Garratt - 10 May 2024 Form 4 Insider Report for AVIENT CORP (AVNT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 May 2024, 15:18:53 UTC
Prior SEC filing
26 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert K. James, Power of Attorney For: Michael A. Garratt

Key filing fact

Michael A. Garratt filed Form 4 for AVIENT CORP (AVNT) on 14 May 2024.

Key facts

  • This page summarizes Michael A. Garratt's Form 4 filing for AVIENT CORP (AVNT).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 14 May 2024, 15:18.

Change

  • Previous filing in this sequence was filed on 26 Feb 2024.
  • Current net transaction value: -$29,644.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVNT transaction

Common Stock

Options Exercise

Transaction value
$462,884
Shares
+11,050
Change %
+38%
Price
$41.89
Shares after
40,224
Date
10 May 2024
Ownership
Direct
AVNT transaction

Common Stock

Tax liability

Transaction value
$474,006
Shares
-10,420
Change %
-26%
Price
$45.49
Shares after
29,804
Date
10 May 2024
Ownership
Direct
AVNT transaction

Common Stock

Options Exercise

Transaction value
$352,084
Shares
+9,200
Change %
+31%
Price
$38.27
Shares after
39,004
Date
10 May 2024
Ownership
Direct
AVNT transaction

Common Stock

Tax liability

Transaction value
$370,607
Shares
-8,147
Change %
-21%
Price
$45.49
Shares after
30,857
Date
10 May 2024
Ownership
Direct
AVNT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,134
Date
10 May 2024
Ownership
Supplemental Plan
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVNT transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-11,050
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,050
Exercise price
$41.89
Footnotes
F2
AVNT transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-9,200
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,200
Exercise price
$38.27
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The information in this report is based on a plan statement as of May 10, 2024.

Footnote F2

SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.

Footnote F3

SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .